My research is focused on investigating the impact of embryonic signalling pathways on cancers such as paediatric solid tumours, brain tumours and lung cancer, with the aim of developing novel therapies and reducing side-effects.
A developmental and cancer biologist, A/Prof Cain is driving cutting-edge research to understand the role of critical embryonic signalling pathways and epigenetic mechanisms in normal and abnormal development and disease, including paediatric connective tissue (sarcomas), paediatric brain cancers (including atypical teratoid rhabdoid tumours and diffuse midline gliomas), and lung adenocarcinoma.